ROLE OF GABA AND OPIOIDS IN THE REGULATION OF THE VASOPRESSIN RESPONSE TO PHYSICAL EXERCISE IN NORMAL MEN

被引:10
作者
CHIODERA, P
VOLPI, R
MAFFEI, ML
CAIAZZA, A
CAFFARRI, G
PAPADIA, C
ALFANO, F
CAPRETTI, L
PAGANI, D
COIRO, V
机构
[1] HOSP PARMA,DIV CARDIOL,PARMA,ITALY
[2] HOSP FIDENZA,DIV INTERNAL MED,FIDENZA,ITALY
[3] HOSP GUASTALLA,RIA LAB,GUASTALLA,ITALY
[4] HOSP CODOGNO,ENDOCRINE UNIT,CODOGNO,ITALY
[5] UNIV PARMA,SCH MED,DEPT INTERNAL MED,I-43100 PARMA,ITALY
关键词
PHYSICAL EXERCISE; SODIUM VALPROATE; NALOXONE;
D O I
10.1016/0167-0115(93)90384-K
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The present study was undertaken in order to establish the possible involvement of GABAergic and/or opioid pathways in the mechanism underlying the arginine-vasopressin (AVP) response to physical exercise. After fasting overnight, seven subjects were tested on four mornings at least 1 week apart. Exercise was performed on a bicycle ergometer. The workload was gradually increased at 3 min intervals until exhaustion and lasted about 15 min in all subjects. Tests were carried out under administration of placebo, the opioid antagonist naloxone (10 mg as an i.v. bolus injection), the GABAergic agonist sodium valproate (600 mg in three divided doses orally) or naloxone plus sodium valproate. Plasma AVP levels rose 4-fold during exercise. The administration of naloxone did not modify, whereas sodium valproate completely abolished the plasma AVP rise during exercise. When naloxone was given together with sodium valproate, AVP rose 3-fold in response to exercise. These data suggest the involvement of a GABAergic mechanism in regulation of the AVP response to physical exercise in men. Furthermore, the data argue against a role of naloxone sensitive endogenous opioids in the control of AVP during exercise, whereas they suggest a partial opioid mediation of the GABAergic inhibitory action.
引用
收藏
页码:57 / 63
页数:7
相关论文
共 43 条
[11]   EFFECTS OF THE GABAERGIC AGENT SODIUM VALPROATE ON THE ARGININE VASOPRESSIN RESPONSES TO HYPERTONIC STIMULATION AND UPRIGHT POSTURE IN MAN [J].
CHIODERA, P ;
GNUDI, A ;
VOLPI, R ;
MARCHESI, C ;
MARCHESI, M ;
DAVOLI, D ;
CAPRETTI, L ;
COIRO, V .
CLINICAL ENDOCRINOLOGY, 1989, 30 (04) :389-395
[12]   GAMMA-AMINOBUTYRIC-ACID MEDIATION OF THE INHIBITORY EFFECT OF ENDOGENOUS OPIOIDS ON THE ARGININE-VASOPRESSIN AND OXYTOCIN RESPONSES TO NICOTINE FROM CIGARETTE-SMOKING [J].
CHIODERA, P ;
VOLPI, R ;
CAPRETTI, L ;
BOCCHI, R ;
CAFFARRI, G ;
MARCATO, A ;
ROSSI, G ;
COIRO, V .
METABOLISM-CLINICAL AND EXPERIMENTAL, 1993, 42 (06) :762-765
[13]   METERGOLINE, NALOXONE, AND SODIUM VALPROATE DID NOT MODIFY ARGININE VASOPRESSIN RESPONSE TO INSULIN-INDUCED HYPOGLYCEMIA IN MAN [J].
CHIODERA, P ;
GNUDI, A ;
VOLPI, R ;
DAMATO, L ;
MARCHESI, C ;
PIOLI, G ;
MUZZETTO, P ;
CASTELLI, A ;
BIANCONI, L ;
MINELLI, R ;
GELMINI, G ;
COIRO, V .
JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION, 1988, 11 (05) :365-369
[14]   NALOXONE INCREASES THE ANGIOTENSIN-II STIMULATED RISE OF ARGININE VASOPRESSIN AND OXYTOCIN SECRETION IN MAN [J].
COIRO, V ;
CHIODERA, P .
NEUROENDOCRINOLOGY, 1991, 53 (03) :209-213
[15]   INHIBITION BY SODIUM VALPROATE OF THE ARGININE VASOPRESSIN AND ADRENOCORTICOTROPIN RESPONSES TO ANGIOTENSIN-II IN NORMAL MEN [J].
COIRO, V ;
CHIODERA, P .
BRAIN RESEARCH, 1989, 491 (01) :169-172
[16]   PLASMA-VOLUME, OSMOLALITY, VASOPRESSIN, AND RENIN-ACTIVITY DURING GRADED-EXERCISE IN MAN [J].
CONVERTINO, VA ;
KEIL, LC ;
BERNAUER, EM ;
GREENLEAF, JE .
JOURNAL OF APPLIED PHYSIOLOGY, 1981, 50 (01) :123-128
[17]  
GREIDANUS TBV, 1985, FRONT HORM RES, V14, P197
[18]   BRAIN OPIATES AND NEUROENDOCRINE FUNCTION [J].
GROSSMAN, A .
CLINICS IN ENDOCRINOLOGY AND METABOLISM, 1983, 12 (03) :725-746
[19]   OPIATE RECEPTORS IN RAT PITUITARY ARE CONFINED TO THE NEURAL LOBE AND ARE EXCLUSIVELY KAPPA [J].
HERKENHAM, M ;
RICE, KC ;
JACOBSON, AE ;
ROTHMAN, RB .
BRAIN RESEARCH, 1986, 382 (02) :365-371
[20]   EFFECT OF NORADRENALINE AND GAMMA-AMINOBUTYRIC ACID ON THE SECRETION OF CORTICOTROPHIN-RELEASING FACTOR-41 AND ARGININE VASOPRESSIN FROM THE RAT HYPOTHALAMUS INVITRO [J].
HILLHOUSE, EW ;
MILTON, NGN .
JOURNAL OF ENDOCRINOLOGY, 1989, 122 (03) :719-723